1. Introduction {#sec1}
===============

NNMT is an enzyme which catalyzes the methylation of nicotinamide (NAM) and produces methylnicotinamide (MNA) \[[@B1], [@B2]\]. Metabolomic works have showed that levels of MNA in urine were correlated with the body mass index (BMI) significantly \[[@B3], [@B4]\]; thus indicating that NNMT is involved in the regulation of the body fat. Recently, these findings have been supported by multiple evidences. For example, serum MNA was reportedly increased in Chinese obesity population \[[@B5]\] and urinary MNA was found elevated in humans with obesity and type 2 diabetes (T2D), in db/db mice and in obese Zucker rats \[[@B4]\]. These results implicate an increased NNMT activity in obesity. The more direct evidences came from Kraus et al. \[[@B6]\] and Lee et al. \[[@B7]\]. They found that*Nnmt* knockdown caused a 47% reduction in relative fat mass of mice \[[@B6]\], and NNMT expression is increased in adipocytes of obese population \[[@B7]\].

More than two hundreds of single nucleotide polymorphisms (SNPs) have been identified within human*NNMT* gene in recent years, and two noncoding region SNPs (rs694539 and rs1941404) have been reported to be significantly associated with some related noncommunicable chronic diseases (NCD), such as hyperhomocysteinemia \[[@B8]\], congenital heart diseases \[[@B9]\], abdominal aortic diseases \[[@B10]\], migraine \[[@B11]\], nonalcoholic steatohepatitis \[[@B12]\], bipolar disorder \[[@B13]\], epilepsy \[[@B14]\], schizophrenia \[[@B15]\], and hyperlipidemia \[[@B16]\]. However, the association between*NNMT* gene SNPs and the body composition has not yet been reported to date.

Are there any SNPs in*NNMT* DNA sequence significantly associated with obesity? We check all the candidate genetic association studies (CGASs) on*NNMT* gene and all the genome-wide association studies (GWASs) on obesity. The results show that no CGAS concerning*NNMT* gene and obesity has been carried out to date and that no SNP in*NNMT* DNA sequence has been identified to be significantly associated with obesity in existing GWASs. Theoretically, it is not surprising that*NNMT* gene is significantly associated with obesity. As the precursor of the NAD^+^, NAM methylation can directly affect NAD^+^ levels, because NAM cannot be used in the synthesis of NAD^+^ if it is methylated by NNMT \[[@B17]\]. NAD^+^ is essential for the fuel oxidation in our bodies. The competition between NNMT and NAD^+^ salvage suggests that*NNMT* gene polymorphisms might affect the fuel oxidation and the storage of fat. Then, why no SNP in*NNMT* gene has been identified to be significantly associated with obesity in GWASs?

In fact, GWASs usually apply strictest genome-wide significance criterion to overcome type I error which makes the false negative discoveries inevitable, therefore a CGAS is still necessary to check whether there are any*NNMT* SNPs significantly associated with the body composition. Moreover, the most existing GWASs used SNP data from HapMap Project, but many more SNPs have been sequenced in 1000 Genome Project nowadays, so it is possible that some significant SNPs in*NNMT* gene were not detected in GWASs.

To test this speculation, a tagSNP based CGAS was carried out in this investigation. Within a candidate gene, the number of SNPs may be large, but direct analysis of all SNPs is inefficient, because the genotypes at many of these loci are strongly correlated. It is a common method to select the maximally informative set of SNPs (tagSNPs) to analyze in a CGAS, thus all known SNPs either are directly assayed or highly associated with a tagSNP \[[@B18]\]. Here, we identified 19 tagSNPs (including rs694539 and rs1941404) across the whole*NNMT* gene DNA sequence using Haploview software (Haploview 4.2) in the first place and then performed a case-control (fat versus thin) study to explore the association between these tagSNPs and obesity.

2. Subjects and Methods {#sec2}
=======================

2.1. Subjects and Grouping {#sec2.1}
--------------------------

783 subjects were selected from Chinese Han male college students (aged from 17 to 23 years). According to their body fat percentage (BF%), the selected subjects were divided into two groups: the high body fat group (HBFG, 19 ≤ BF%, *n* = 289) and the low body fat group (LBFG, 3 ≤ BF% \< 13.5, *n* = 494). The inclusion criteria were free of any diagnosed diseases (especially the anorexia, bulimia nervosa, and the diseases in the digestive system), without partiality for a particular kind of food and without exercise habit. The local ethics committee of Jiangxi Normal University approved this investigation, and the written informed consent was given to all the participants. This study conforms to the latest revision of the Declaration of Helsinki.

2.2. Body Component Measurement {#sec2.2}
-------------------------------

Body component was measured using bioimpedance measurement with an X-SCAN PLUS body composition analyzer (X-SCAN PLUSII, Jawon Medical Co., Ltd., South Korea). Measurements were performed in the morning with empty stomachs.

2.3. SNP Selection and Genotyping {#sec2.3}
---------------------------------

As mentioned above, there are many SNPs in*NNMT* gene. To determine the investigation of loci, a tagSNP approach was used \[[@B18]\]. With the criteria (MAF \> 0.10 and *r*^2^ \> 0.8), nineteen tagSNPs were selected using Haploview software (Haploview 4.2) from the known SNP data in the Chinese Han population (CHB + CHS), which were downloaded from the database, 1000 Genomes Project (<http://browser.1000genomes.org>). Genomic DNA was extracted from blood samples with DNA extraction kits (Promega, USA). The gene sequence was downloaded from the database of National Center for Biotechnology Information (NCBI). Both probes and primers were designed with online software Primer 3 (<http://bioinfo.ut.ee/primer3-0.4.0>). Genotypes of the SNPs were detected by polymerase chain reaction-ligase detection reaction (PCR-LDR) \[[@B17]\]. Ten percent of the PCR-LDR reactions were performed in duplicate to check the reliability of the genotyping, and more than 99.5% of them had the matching results. Additionally, Sanger sequencing method was used to genotype the significantly associated tagSNP (rs10891644) of 30 samples randomly selected, and 100% had the matching results with the PCR-LDR method.

2.4. Statistics {#sec2.4}
---------------

The frequency distributions of genotype and allele and Hardy--Weinberg equilibrium (HWE) were analyzed online (<http://analysis.bio-x.cn>). The HWE tests only performed in the control group. Four genetic models provided by Zintzaras and Santos \[[@B19]\] and two classification logistic regressions were used in the genotype effects analyses. The mean values were compared with one-way ANOVA with IBM SPSS Statistics 20.0 (SPSS Inc., Chicago, IL, USA). *P* value \< 0.05 was considered statistically significant. Bonferroni correction was performed for the analysis of the genotype and allele frequency distributions, and the corrected significance level was *P* \< 0.0026. The *P* values and the odds ratios were adjusted for the age in the analysis of the genotype effects.

3. Results and Discussions {#sec3}
==========================

3.1. The Distributions of Alleles and Genotypes of the 19 Tag SNPs {#sec3.1}
------------------------------------------------------------------

The allele and genotype distributions of the 19 tagSNPs are shown in the [Table 1](#tab1){ref-type="table"}. Among these SNPs, rs10891644 was the only one significantly associated SNP after Bonferroni correction (*P* \< 0.0026) and qualified with HWE test (*P* \> 0.05). At this locus, the HBLG exhibited a higher allele T frequency and a higher genotype GT frequency than the LBFG did. Thus the rs10891644 variation was focused in the rest analyses and the other SNPs were not analyzed any longer.

3.2. Genotype Effects and Genetic Models of rs10891644 Variation {#sec3.2}
----------------------------------------------------------------

Genetic models (dominant, recessive, additive, and codominant) are often used in genotype effect analyses. However, these models are not totally independent. To avoid hash of these models, a whole solution and the degree of dominance (*h*) were offered by Zintzaras and Santos \[[@B19]\]. As shown in the [Table 2](#tab2){ref-type="table"}, chances of subjects of the genotypes GG, GT, and TT to be the HBFG were 31%, 44%, and 35%, respectively. Two classification logistic regression analyses suggested that the dominant model and the codominance model were both significant (*P*~adjusted~ \< 0.05) after the adjustment for age, and the adjusted degree of dominance (*h*~adjusted~) was less than −1 (\|*h*\| \> 1 indicates that the phenotype of heterozygotes lies outside the phenotypical range of both homozygotes). Based on the *P*~adjusted~ values, these results indicate that the possible inheritance modes of the rs10891644 variation are dominant or codominant. However, the *P*~adjusted~ value of the additive model (GG versus TT) demonstrated that the difference between the homozygous GG and TT was not significant (*P*~adjusted~ \> 0.05), which denied the dominant mode, because in the dominant mode the difference between the homozygous genotypes must be significantly different. To determine whether the inheritance mode is overdominant, the *h*~adjusted~ value has been calculated, and the *h*~adjusted~ = 2.57 strongly suggests that the inheritance mode of the rs10891644 variation is overdominant. Overdominant inheritance is a condition in genetics where the phenotype of the heterozygote lies outside the phenotypical range of both homozygotes, which usually is described as heterosis, wherein heterozygous individuals have advantages in the natural selection. In this study, the OR~adjusted~ value of the GT versus (GG + TT) was 1.716, which means that the chance of the GT being of HBFG is 1.716 times that of the homozygous (GG + TT), thus indicating that the heterozygous individuals (GT carriers) are the susceptible population to obesity. It is worth noting that although many diseases are associated with obesity nowadays, fat storage might be very helpful to enhance survival chances when lack of food in the long history of mankind. Therefore, it may be a result from the natural selection that the heterozygous individuals (GT carriers) are the susceptible population to obesity.

To further justify the genotype effects of the rs10891644 variation shown in [Table 2](#tab2){ref-type="table"}, we compared the BF% between the subjects with different genotypes. As shown in [Figure 1](#fig1){ref-type="fig"}, the BF% of the GT, TT, and GG carriers were 14.56 ± 8.35, 13.47 ± 8.11, and 12.42 ± 7.50, the highest was the GT carriers followed by the TT and the GG carriers, and there were highly significant differences (*P* \< 0.01) between the GT and the GG carriers, between the GT and the GG + TT carriers (codominant model), and between the GT + TT and the GG carriers (dominant model), respectively, while there were no significant differences between the GG and TT carriers (additive model) and between the TT and the GG + GT carriers (recessive model) (*P* \> 0.05). These results further demonstrated that the body composition is significantly affected by the rs10891644 variation, and the inheritance mode of the rs10891644 variation is overdominant.

As mentioned above, although no*NNMT* gene SNP had been reported to be significantly associated with obesity before this paper, numerous reports have confirmed the roles of NNMT in regulation of the body composition. Among individuals, NNMT activity varies fivefold and has a bimodal frequency distribution in livers \[[@B20]\], but when the cDNAs of individuals with high and low NNMT activity were compared, no sequence differences were seen \[[@B21]\]. Thus the differences of phenotypes are due to the differences at transcriptional level and not because of*NNMT* SNPs in the coding regions \[[@B21]\].*NNMT* gene is highly polymorphic in humans, and most of which are in the noncoding regions of this gene. The tagSNP (rs10891644), which was found significantly associated with obesity in this study, is also in the noncoding region (5′ near gene). Therefore, it presumably affects the transcription of*NNMT* gene, thus causing the genetic risk for fat storage.

The existing reports have shown that NMT plays roles in the regulation of energy metabolism \[[@B6], [@B22], [@B23]\] and the body composition \[[@B3]--[@B7]\]. Therefore it is reasonable that*NNMT* gene polymorphism is associated with obesity. However, besides the genetic factor, many other factors are also related to obesity, such as race, gender, age, diet, exercise, and the gut microbiome \[[@B23]--[@B29]\]. To maximally eliminate the influences from other factors, we recruited the subjects from Chinese Han male college students, who were free of any diagnosed diseases (especially the anorexia, bulimia nervosa, and the diseases in the digestive system), without partiality for a particular kind of food and without exercise habit, and did the adjustment for age. The limitations of this investigation are that all participants were not entirely on the same controlled diet and that the influences of gut microbiome could not be eliminated.

In summary, for the first time we found that a tagSNP (rs10891644) in*NNMT* gene is significantly associated with obesity and the heterozygous individuals (GT carriers at this locus) are the susceptible population. Although the precise mechanism of the regulation process still needs further investigation, our findings suggest that the variant of a tagSNP (rs10891644) in*NNMT* gene is involved in the etiopathology of obesity in Chinese Han male college students.
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![Comparisons of the body fat percentage between the different genotypes. GT, the genotype GT (*n* = 336); TT, the genotype TT (*n* = 82); GG, the genotype GG (*n* = 354); GT + TT, the genotypes (GT + TT) (*n* = 418); GG + GT, the genotypes (GG + GT) (*n* = 690); GG + TT, the genotypes (GG + TT) (*n* = 436). ^*∗∗*^*P* \< 0.01 compared with GT; ^\#\#^*P* \< 0.01 compared with GG. Error bars, ± standard deviation.](BMRI2017-2984826.001){#fig1}

###### 

The distribution of alleles and genotypes of the 19 tag SNPs.

  SNPs         Allele frequency   *P*             Genotype frequency   HWE              *P*                                                    
  ------------ ------------------ --------------- -------------------- ---------------- ---------------- ---------------- ---------------- --- -------------
  rs2511153    Case               C: 352 (0.63)   T: 206 (0.37)        0.708            CC: 108 (0.39)   CT: 57 (0.44)    TT: 20 (0.16)        0.827
  Ctrl.        C: 625 (0.64)      T: 351 (0.36)   CC: 199 (0.41)       CT: 227 (0.47)   TT: 62 (0.13)    0.83                                  
  rs505978     Case               A: 307 (0.54)   C: 261 (0.46)        0.668            AA: 80 (0.28)    AC: 254 (0.52)   CC: 57 (0.20)        0.909
  Ctrl.        A: 544 (0.55)      C: 442 (0.45)   AA: 145 (0.29)       AC: 66 (0.50)    CC: 94 (0.19)    0.36                                  
  rs694539     Case               A: 192 (0.34)   G: 374 (0.66)        0.613            AA: 30 (0.11)    AG: 132 (0.47)   GG: 121 (0.43)       0.861
  Ctrl.        A: 347 (0.35)      G: 639 (0.65)   AA: 55 (0.11)        AG: 237 (0.48)   GG: 201 (0.41)   0.23                                  
  rs12285641   Case               C: 349 (0.62)   T: 217 (0.38)        0.817            CC: 102 (0.36)   CT: 145 (0.51)   TT: 36 (0.13)        0.820
  Ctrl.        C: 585 (0.61)      T: 373 (0.39)   CC: 174 (0.36)       CT: 237 (0.50)   TT: 68 (0.14)    0.38                                  
  rs11214926   Case               A: 154 (0.27)   G: 410 (0.73)        0.871            AA: 18 (0.06)    AG: 118 (0.42)   GG: 146 (0.52)       0.810
  Ctrl.        A: 273 (0.28)      G: 713 (0.72)   AA: 28 (0.06)        AG: 217 (0.44)   GG: 248 (0.50)   0.03                                  
  rs7109984    Case               C: 502 (0.89)   T: 64 (0.11)         0.221            CC: 224 (0.79)   CT: 54 (0.19)    TT: 5 (0.02)         0.407
  Ctrl.        C: 829 (0.87)      T: 129 (0.14)   CC: 359 (0.75)       CT: 111 (0.23)   TT: 9 (0.02)     0.90                                  
  rs10891644   Case               G: 370 (0.64)   T: 206 (0.36)        0.029^*∗*^       GG: 111 (0.39)   GT: 148 (0.51)   TT: 29 (0.10)        0.002^*∗∗*^
  Ctrl.        G: 674 (0.70)      T: 294 (0.30)   GG: 243 (0.50)       GT: 188 (0.39)   TT: 53 (0.11)    0.07                                  
  rs55675450   Case               A: 88 (0.16)    G: 470 (0.84)        0.368            AA: 5 (0.02)     AG: 78 (0.28)    GG: 196 (0.70)       0.056
  Ctrl.        A: 138 (0.14)      G: 842 (0.86)   AA: 17 (0.04)        AG: 104 (0.21)   GG: 369 (0.75)   0.01                                  
  rs2244175    Case               A: 274 (0.48)   G: 292 (0.52)        0.147            AA: 64 (0.23)    AG: 146 (0.52)   GG: 73 (0.26)        0.337
  Ctrl.        A: 515 (0.52)      G: 471 (0.48)   AA: 132 (0.27)       AG: 251 (0.51)   GG: 110 (0.22)   0.65                                  
  rs2847492    Case               A: 198 (0.35)   G: 368 (0.65)        0.162            AA: 33 (0.12)    AG: 132 (0.47)   GG: 118 (0.42)       0.366
  Ctrl.        A: 380 (0.39)      G: 606 (0.62)   AA: 72 (0.15)        AG: 236 (0.48)   GG: 185 (0.38)   0.82                                  
  rs2852432    Case               C: 336 (0.59)   T: 232 (0.41)        0.209            CC: 94 (0.33)    CT: 148 (0.52)   TT: 42 (0.15)        0.286
  Ctrl.        C: 551 (0.56)      T: 435 (0.44)   CC: 153 (0.31)       CT: 245 (0.50)   TT: 95 (0.19)    0.86                                  
  rs4646335    Case               A: 326 (0.57)   T: 242 (0.43)        0.387            AA: 89 (0.31)    AT: 148 (0.52)   TT: 47 (0.17)        0.666
  Ctrl.        A: 588 (0.60)      T: 398 (0.40)   AA: 169 (0.34)       AT: 250 (0.51)   TT: 74 (0.15)    0.24                                  
  rs3819100    Case               A: 282 (0.50)   G: 284 (0.50)        0.597            AA: 70 (0.25)    AG: 142 (0.50)   GG: 71 (0.25)        0.825
  Ctrl.        A: 505 (0.51)      G: 481 (0.49)   AA: 126 (0.26)       AG: 253 (0.51)   GG: 114 (0.23)   0.55                                  
  rs2256292    Case               C: 234 (0.41)   G: 338 (0.59)        0.417            CC: 50 (0.18)    CG: 134 (0.47)   GG: 102 (0.36)       0.526
  Ctrl.        C: 382 (0.39)      G: 602 (0.61)   CC: 71 (0.14)        CG: 240 (0.49)   GG: 181 (0.37)   0.55                                  
  rs2301128    Case               A: 81 (0.15)    G: 477 (0.86)        0.071            AA: 3 (0.01)     AG: 75 (0.27)    GG: 201 (0.72)       0.051
  Ctrl.        A: 111 (0.11)      G: 867 (0.89)   AA: 8 (0.02)         AG: 95 (0.19)    GG: 386 (0.79)   0.44                                  
  rs1941404    Case               C: 265 (0.47)   T: 301 (0.53)        0.472            CC: 59 (0.21)    CT: 147 (0.52)   TT: 77 (0.27)        0.762
  Ctrl.        C: 443 (0.45)      T: 543 (0.55)   CC: 94 (0.19)        CT: 255 (0.52)   TT: 144 (0.29)   0.32                                  
  rs2155806    Case               C: 59 (0.11)    T: 499 (0.89)        0.200            CC: 1 (0.00)     CT: 57 (0.20)    TT: 221 (0.79)       0.387
  Ctrl.        C: 125 (0.13)      T: 853 (0.87)   CC: 4 (0.01)         CT: 117 (0.24)   TT: 368 (0.75)   0.11                                  
  rs1941399    Case               A: 102 (0.18)   C: 464 (0.82)        0.425            AA: 4 (0.01)     AC: 94 (0.33)    CC: 185 (0.65)       0.152
  Ctrl.        A: 194 (0.20)      C: 792 (0.80)   AA: 19 (0.04)        AC: 156 (0.32)   CC: 318 (0.65)   0.98                                  
  rs4646337    Case               A: 479 (0.86)   G: 79 (0.14)         0.935            AA: 201 (0.72)   AG: 77 (0.28)    GG: 1 (0.00)         0.102
  Ctrl.        A: 841 (0.86)      G: 137 (0.14)   AA: 362 (0.74)       AG: 117 (0.24)   GG: 10 (0.02)    0.88                                  

HWE, Hardy--Weinberg equilibrium; Case, the high body fat group; Ctrl., the low body fat group. HWE, *P* value of Hardy--Weinberg equilibrium test on the control group; the values of allele and genotype are the number of individuals (frequency); ^*∗*^*P* \< 0.05; ^*∗∗*^*P* \< 0.01.

###### 

Genotype effects and genetic models of the rs10891644 variation.

  ---------------------------------------------------------------------------------------------------------------------------------
  Model        Genotype     HBFG         LBFG         OR (95% CI)      Adjusted\        *P* (*P*~adjusted~)   *h* (*h*~adjusted~)
                                                                       OR (95% CI)                            
  ------------ ------------ ------------ ------------ ---------------- ---------------- --------------------- ---------------------
  Recessive    TT           29 (0.35)    53 (0.65)    0.911\           0.932\           0.701 (0.802)         2.83 (2.57)
                                                      (0.564, 1.469)   (0.538, 1.614)                         

  (GT + GG)    259 (0.38)   431 (0.62)                                                                        

  Dominant     (TT + GT)    177 (0.42)   241 (0.58)   1.608\           1.669\           0.002 (0.003)^*∗∗*^   
                                                      (1.195, 2.163)   (1.188, 2.345)                         

  GG           111 (0.31)   243 (0.69)                                                                        

  Additive     TT           29 (0.35)    53 (0.65)    1.198\           1.239\           0.484 (0.468)         
                                                      (0.723, 1.985)   (0.695, 2.208)                         

  GG           111 (0.31)   243 (0.69)                                                                        

  Codominant   GT           148 (0.44)   188 (0.56)   1.664\           1.716\           0.001 (0.002)^*∗∗*^   
                                                      (1.240, 2.235)   (1.220, 2.413)                         

  (TT + GG)    140 (0.32)   296 (0.68)                                                                        
  ---------------------------------------------------------------------------------------------------------------------------------

HBFG, the high body fat group; LBFG, the low body fat group; the values of HBFG and LBFG are the number of individuals (ratio) from different genotypes; OR, odds ratio; CI, confidence interval; *h* (dominance degree) = ln⁡(OR~co~)/ln⁡(OR~a~), OR~co~, OR of the codominant model, OR~a~, OR of the additive model, \|*h*\| \> 1 indicates that the phenotype of the heterozygotes lies outside the phenotypical range of both homozygotes; Adjusted, adjustment for age. ^*∗∗*^*P* \< 0.01.

[^1]: Academic Editor: Hai-Feng Pan
